MedTrace Logo

Computer Aided, Non-invasive, Acoustic Gastrointestinal Surveillance in Post-ERCP Pancreatitis

NCT02433444 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2015-05-05

No results posted yet for this study

Summary

In this study, the investigators aim to distinguish patients with Post-Endoscopic retrograde cholangiopancreatography (ERCP) Pancreatitis (PEP) vs. those without PEP based on difference in pre- vs. post-ERCP measurements of AGIS-derived intestinal rates (IR). Based on the clinical observation that many patients with PEP develop ileus following ERCP, the investigators hypothesize that patients who develop PEP will exhibit lower IR following ERCP, and therefore a larger difference in pre- vs. post-ERCP IR.

Conditions

Interventions

PROCEDURE

Endoscopic retrograde cholangiopancreatography (ERCP)

ERCP's performed at Cedars-Sinai Medical Center.

Sponsors & Collaborators

Principal Investigators

  • Elham Afghani, MD · Cedars-Sinai Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-12-31
Completion
2016-12-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02433444 on ClinicalTrials.gov